Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nedaa Alomari

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Viruses|October 27, 2022
Host-Level Susceptibility and IRF1 Expression Influence the Ability of IFN-γ to Inhibit KSHV Infection in B LymphocytesNedaa Alomari, Jennifer Totonchy
Frontiers in Immunology|December 26, 2022
IL-21 signaling promotes the establishment of KSHV infection in human tonsil lymphocytes by increasing differentiation and targeting of plasma cellsNedaa Alomari, Jennifer Totonchy
Frontiers in Pharmacology|February 23, 2024
Update on the advances and challenges in bioequivalence testing methods for complex topical generic productsNedaa Alomari, Waleed Alhussaini
Viruses|October 1, 2020
Cytokine-Targeted Therapeutics for KSHV-Associated DiseaseNedaa Alomari, Jennifer Totonchy
International Journal of Molecular Sciences|November 17, 2017
Primary Cilium-Dependent Signaling MechanismsRajasekharreddy Pala, Nedaa Alomari, Surya M Nauli
BMC Neurology|April 5, 2025
Drug-resistant epilepsy in Saudi Arabia: prevalence, predictive factors, and treatment outcomesMeshari Alghamdi, Nedaa Alomari, Aser F Alamri, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Viruses|October 27, 2022
Host-Level Susceptibility and IRF1 Expression Influence the Ability of IFN-γ to Inhibit KSHV Infection in B LymphocytesNedaa Alomari, Jennifer Totonchy
Frontiers in Immunology|December 26, 2022
IL-21 signaling promotes the establishment of KSHV infection in human tonsil lymphocytes by increasing differentiation and targeting of plasma cellsNedaa Alomari, Jennifer Totonchy
Frontiers in Pharmacology|February 23, 2024
Update on the advances and challenges in bioequivalence testing methods for complex topical generic productsNedaa Alomari, Waleed Alhussaini
Viruses|October 1, 2020
Cytokine-Targeted Therapeutics for KSHV-Associated DiseaseNedaa Alomari, Jennifer Totonchy
International Journal of Molecular Sciences|November 17, 2017
Primary Cilium-Dependent Signaling MechanismsRajasekharreddy Pala, Nedaa Alomari, Surya M Nauli
BMC Neurology|April 5, 2025
Drug-resistant epilepsy in Saudi Arabia: prevalence, predictive factors, and treatment outcomesMeshari Alghamdi, Nedaa Alomari, Aser F Alamri, et al.
Pageof 1